| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 146, Issue 12 4301-4307, Copyright © 1991 by American Association of Immunologists
ARTICLES |
D Binder and TM Kundig
Institute of Pathology, University of Zurich, Switzerland.
T cell-mediated protection against a recombinant vaccinia virus was evaluated in mice with respect to the relative contributions of CTL vs that of T cell-dependent IL and of CD4+ cells. H-2b mice primed with the wildtype of vesicular stomatitis virus serotype Indiana (VSV-IND wt) mount an in vitro measurable cytotoxic response against the nucleoprotein (NP) of VSV-IND and are protected against a challenge infection with a vaccinia-VSV recombinant virus expressing the NP of VSV-IND (vacc-IND-NP). Their protective mechanism was highly susceptible to in vivo depletion of CD8+ T cells, but resistant to CD4+ depletion or treatment with anti-IFN-gamma and anti-TNF-alpha. Surprisingly, also VSV-CTL nonresponder H-2k mice were protected against a challenging infection with vacc-IND-NP when primed with VSV- IND wt. In contrast to the CTL responder H-2b mice, this protection was highly susceptible to CD4+ T cell depletion and to anti-IFN-gamma or anti-TNF-alpha treatment, but resistant to CD8+ T cell depletion. Antibodies were not responsible because they failed to transfer protection; in contrast CD4+ T cells conferred significant protection. VSV-CTL responder H-2b and nonresponder H-2k mice were protected almost equally well against a challenge dose of 10(3) pfu vacc-IND-NP inoculated intracerebrally. However, after intracerebral challenge with 5 x 10(6) pfu vacc-IND-NP, the CTL nonresponder mice died, whereas the CTL responder mice eliminated the virus by day 5. These results collectively show that CD4+ T cell-dependent IL may mediate antiviral protection, but their efficiency is relatively weak compared with CD8- mediated protection correlating with cytotoxic activity in vitro.
This article has been cited by other articles:
|
|
 |
|
  H. Ito, K. Ando, T. Ishikawa, T. Nakayama, M. Taniguchi, K. Saito, M. Imawari, H. Moriwaki, T. Yokochi, S. Kakumu, et al. Role of V{alpha}14+ NKT cells in the development of Hepatitis B virus-specific CTL: activation of V{alpha}14+ NKT cells promotes the breakage of CTL tolerance Int. Immunol., July 1, 2008; 20(7): 869 - 879. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Davis, K. A. Hagan, L. A. Matthews, G. Bajwa, M. A. Gill, M. Gale Jr., and J. D. Farrar Blockade of Virus Infection by Human CD4+ T Cells via a Cytokine Relay Network J. Immunol., May 15, 2008; 180(10): 6923 - 6932. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Johansen, T. Storni, L. Rettig, Z. Qiu, A. Der-Sarkissian, K. A. Smith, V. Manolova, K. S. Lang, G. Senti, B. Mullhaupt, et al. Antigen kinetics determines immune reactivity PNAS, April 1, 2008; 105(13): 5189 - 5194. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Firat, L. Saveanu, P. Aichele, P. Staeheli, J. Huai, S. Gaedicke, A. Nil, G. Besin, B. Kanzler, P. van Endert, et al. The Role of Endoplasmic Reticulum-Associated Aminopeptidase 1 in Immunity to Infection and in Cross-Presentation J. Immunol., February 15, 2007; 178(4): 2241 - 2248. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Bolesta, A. Kowalczyk, A. Wierzbicki, C. Eppolito, Y. Kaneko, M. Takiguchi, L. Stamatatos, P. A. Shrikant, and D. Kozbor Increased Level and Longevity of Protective Immune Responses Induced by DNA Vaccine Expressing the HIV-1 Env Glycoprotein when Combined with IL-21 and IL-15 Gene Delivery J. Immunol., July 1, 2006; 177(1): 177 - 191. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. F. Bachmann, P. Wolint, K. Schwarz, and A. Oxenius Recall Proliferation Potential of Memory CD8+ T Cells and Antiviral Protection J. Immunol., October 1, 2005; 175(7): 4677 - 4685. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Fassnacht, A. Ackermann, P. Staeheli, and J. Hausmann Immunization with dendritic cells can break immunological ignorance toward a persisting virus in the central nervous system and induce partial protection against intracerebral viral challenge J. Gen. Virol., August 1, 2004; 85(8): 2379 - 2387. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. N. Kristensen, A. N. Madsen, A. R. Thomsen, and J. P. Christensen Cytokine production by virus-specific CD8+ T cells varies with activation state and localization, but not with TCR avidity J. Gen. Virol., June 1, 2004; 85(6): 1703 - 1712. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Karrer, M. Wagner, S. Sierro, A. Oxenius, H. Hengel, T. Dumrese, S. Freigang, U. H. Koszinowski, R. E. Phillips, and P. Klenerman Expansion of Protective CD8+ T-Cell Responses Driven by Recombinant Cytomegaloviruses J. Virol., March 1, 2004; 78(5): 2255 - 2264. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kasahara, K. Ando, K. Saito, K. Sekikawa, H. Ito, T. Ishikawa, H. Ohnishi, M. Seishima, S. Kakumu, and H. Moriwaki Lack of Tumor Necrosis Factor Alpha Induces Impaired Proliferation of Hepatitis B Virus-Specific Cytotoxic T Lymphocytes J. Virol., February 15, 2003; 77(4): 2469 - 2476. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Storni, F. Lechner, I. Erdmann, T. Bachi, A. Jegerlehner, T. Dumrese, T. M. Kundig, C. Ruedl, and M. F. Bachmann Critical Role for Activation of Antigen-Presenting Cells in Priming of Cytotoxic T Cell Responses After Vaccination with Virus-Like Particles J. Immunol., March 15, 2002; 168(6): 2880 - 2886. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Erdmann, E. P. Scheidegger, F. K. Koch, L. Heinzerling, B. Odermatt, G. Burg, J. B. Lowe, and T. M. Kundig Fucosyltransferase VII-Deficient Mice with Defective E-, P-, and L-Selectin Ligands Show Impaired CD4+ and CD8+ T Cell Migration into the Skin, but Normal Extravasation into Visceral Organs J. Immunol., March 1, 2002; 168(5): 2139 - 2146. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Zhong, A. D. Roberts, and D. L. Woodland Antibody-Independent Antiviral Function of Memory CD4+ T Cells In Vivo Requires Regulatory Signals from CD8+ Effector T Cells J. Immunol., August 1, 2001; 167(3): 1379 - 1386. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. Ahlers, I. M. Belyakov, S. Matsui, and J. A. Berzofsky Mechanisms of cytokine synergy essential for vaccine protection against viral challenge Int. Immunol., July 1, 2001; 13(7): 897 - 908. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. J. Maloy, I. Erdmann, V. Basch, S. Sierro, T. A. Kramps, R. M. Zinkernagel, S. Oehen, and T. M. Kündig Intralymphatic immunization enhances DNA vaccination PNAS, February 22, 2001; (2001) 51630798. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. Moretto, L. Casciotti, B. Durell, and I. A. Khan Lack of CD4+ T Cells Does Not Affect Induction of CD8+ T-Cell Immunity against Encephalitozoon cuniculi Infection Infect. Immun., November 1, 2000; 68(11): 6223 - 6232. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. J. Maloy, C. Burkhart, T. M. Junt, B. Odermatt, A. Oxenius, L. Piali, R. M. Zinkernagel, and H. Hengartner CD4+ T Cell Subsets during Virus Infection: Protective Capacity Depends on Effector Cytokine Secretion and on Migratory Capability J. Exp. Med., June 19, 2000; 191(12): 2159 - 2170. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Andersen, T. Jensen, A. Nansen, O. Marker, and A. R. Thomsen CD4+ T cell-mediated protection against a lethal outcome of systemic infection with vesicular stomatitis virus requires CD40 ligand expression, but not IFN-{gamma} or IL-4 Int. Immunol., December 1, 1999; 11(12): 2035 - 2042. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Marais,, J.-A. Passmore,, J. Maclean,, R. Rose, and A.-L. Williamson A recombinant human papillomavirus (HPV) type 16 L1-vaccinia virus murine challenge model demonstrates cell-mediated immunity against HPV virus-like particles J. Gen. Virol., September 1, 1999; 80(9): 2471 - 2475. [Abstract] [Full Text]
|
|
|
|
|
|
I. A. Khan, J. D. Schwartzman, L. H. Kasper, and M. Moretto CD8+ CTLs Are Essential for Protective Immunity Against Encephalitozoon cuniculi Infection J. Immunol., May 15, 1999; 162(10): 6086 - 6091. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Oxenius, M. M. A. Martinic, H. Hengartner, and P. Klenerman CpG-Containing Oligonucleotides Are Efficient Adjuvants for Induction of Protective Antiviral Immune Responses with T-Cell Peptide Vaccines J. Virol., May 1, 1999; 73(5): 4120 - 4126. [Abstract] [Full Text]
|
|
|
|
|
|
M. C. Villacres and C. C. Bergmann Enhanced Cytotoxic T Cell Activity in IL-4-Deficient Mice J. Immunol., March 1, 1999; 162(5): 2663 - 2670. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. J. Maloy, C. Burkhart, G. Freer, T. Rulicke, H. Pircher, D. H. Kono, A. N. Theofilopoulos, B. Ludewig, U. Hoffmann-Rohrer, R. M. Zinkernagel, et al. Qualitative and Quantitative Requirements for CD4+ T Cell-Mediated Antiviral Protection J. Immunol., March 1, 1999; 162(5): 2867 - 2874. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Oxenius, U. Karrer, R. M. Zinkernagel, and H. Hengartner IL-12 Is Not Required for Induction of Type 1 Cytokine Responses in Viral Infections J. Immunol., January 15, 1999; 162(2): 965 - 973. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Oehen and K. Brduscha-Riem Differentiation of Naive CTL to Effector and Memory CTL: Correlation of Effector Function with Phenotype and Cell Division J. Immunol., November 15, 1998; 161(10): 5338 - 5346. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Seiler, M.-A. Brundler, C. Zimmermann, D. Weibel, M. Bruns, H. Hengartner, and R. M. Zinkernagel Induction of Protective Cytotoxic T Cell Responses in the Presence of High Titers of Virus-neutralizing Antibodies: Implications for Passive and Active Immunization J. Exp. Med., February 16, 1998; 187(4): 649 - 654. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U Muller, U Steinhoff, L. Reis, S Hemmi, J Pavlovic, R. Zinkernagel, and M Aguet Functional role of type I and type II interferons in antiviral defense Science, June 24, 1994; 264(5167): 1918 - 1921. [Abstract] [PDF]
|
|
|
|
|
|
S Huang, W Hendriks, A Althage, S Hemmi, H Bluethmann, R Kamijo, J Vilcek, R. Zinkernagel, and M Aguet Immune response in mice that lack the interferon-gamma receptor Science, March 19, 1993; 259(5102): 1742 - 1745. [Abstract] [PDF]
|
|
|
|
|
|
K. J. Maloy, I. Erdmann, V. Basch, S. Sierro, T. A. Kramps, R. M. Zinkernagel, S. Oehen, and T. M. Kundig Intralymphatic immunization enhances DNA vaccination PNAS, March 13, 2001; 98(6): 3299 - 3303. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
